BGN and myocardial infarction: To this end, biglycan is implicated in kidney disease [15], the regulation of inflammation and autophagy in cancer [16], cardiac hypertrophy [17], erythropoietin production [18], autoimmune perimyocarditis [19], and adaptive remodeling after myocardial infarction [20].